SERA

SERA

Sera Prognostics Takes Significant Leap Forward in Commercialization Phase with Strong Q3 2026 Results

Sera Prognostics, a leader in advanced lab tests, has reported significant progress in its commercialization phase during the third quarter of 2026. The company's President and Chief Executive Officer, Zhenya Lindgardt, highlighted the strong momentum achieved in Q3 during the recent earnings conference call. In a notable achievement,

SERA

Sera Prognostics Hits Key Milestones in Second Quarter 2026: Expanding Commercial Engagements and Unlocking Policy Momentum

Sera Prognostics, a leading developer of innovative diagnostic solutions for high-risk pregnancy, marked significant progress in the second quarter of 2026. The company's President and Chief Executive Officer, Zhenya Lindgardt, highlighted several key wins during the quarterly earnings conference call. The quarter saw Sera expand commercial engagements through